Red soapwort

Red Soapwort (Saponaria ocymoides L.): A Comprehensive Reference

1. Identity, Nomenclature, and Botanical Description

1.1 Taxonomic Identity

Saponaria ocymoides, the rock soapwort or tumbling Ted, is a species of semi-evergreen perennial flowering plant belonging to the family Caryophyllaceae, native to southwestern and southern central Europe. It is the species most frequently designated by the common name "red soapwort," a reference to the reddish coloration of its stems and the pink-to-red hue of its flowers. Rock soapwort belongs to the Caryophyllaceae family, which includes carnations and other perennial herbs.

The name Saponaria is derived from the Latin word sapo, meaning soap. The specific epithet ocymoides means "resembling basil" (genus: Ocimum), and may refer to the shape of the leaves or the highly branched habit. From this same Latin word is derived the name of the toxic substance saponin, contained in the roots.

It is important to understand that Saponaria ocymoides belongs to a broader genus of medicinally relevant plants. There are at least 20 different types of Saponaria plants grown worldwide, including the two most well-known: red soapwort and white soapwort. The closely related species Saponaria officinalis L. (common soapwort, bouncing bet, or fuller's herb) shares overlapping chemistry, traditional uses, and pharmacological properties; much of the available scientific research applies to the genus broadly or specifically to S. officinalis, the more widely studied species. Where research is species-specific, this is noted below.

Agrostemma githago, Dianthus chinensis, D. caryophyllus, D. barbatus, Gypsophila paniculata, Lychnis coronaria, Saponaria officinalis, S. ocymoides, and Silene spp. are known as ornamental species within the family Caryophyllaceae.

Recognized synonyms for S. ocymoides include: Bootia ocymoides Neck. ex Rchb., Lychnis ocymoides Jess., Saponaria repens Lam., Saponaria viscosa Dulac, Silene alsinoides Viv., and Silene ocymoides E.H.L.Krause; distributed across Austria, Corsica, France, Germany, Italy, Sardinia, Spain, Switzerland, and former Yugoslavia.

1.2 Morphological Description

Reaching a height of 10–40 centimetres, the stem is prostrate to ascending, woody, reddish, quite hairy, and very branched. The leaves are ovate to lanceolate, sessile and hairy, 1–3 cm long. The five-petalled flowers are arranged in groups at the ends of branches, and they have red or pink (rarely white) petals and blue anthers. The sepals are fused in a tube about 8 to 10 millimetres long. The flowering period extends from May to August in the Northern Hemisphere.

Rock soapwort is a semi-evergreen herbaceous perennial ground cover native to the rocky, mountainous slopes of southwestern and south central Europe. The stems have a reddish coloration and can be semi-woody, and both the stems and leaves are covered in fine hairs. These reddish stems, combined with the characteristically bright pink-red flowers, give the plant its common designation as "red soapwort."

1.3 Common Names and Preparations

Beyond "red soapwort" and "rock soapwort," the broader soapwort genus is known by numerous folk names. There are innumerable common names relating to the plant's use as a soap, such as Bouncing Bet, Fuller's-herb, Lady's-washbowl, Latherwort, Sheepweed, and Old-maid's-pink. Soapwort also goes by other names, including bouncing-bet, crow soap, wild sweet William, and soapweed.

Common forms and preparations encountered in traditional use and commercial contexts include:

• Root decoctions (boiling dried root in water)
• Leaf and stem infusions
• Dried root powder for internal or external use
• Hydroalcoholic (ethanol, methanol, acetone) root extracts
• Leaf or root extracts listed in cosmetology products under the INCI name Saponaria Officinalis Leaf/Root Extract
• Saponin-standardized capsule formulations (used in some research contexts)
• Natural soap preparations made by boiling crushed root in water

2. Traditional and Historical Use

2.1 Ancient and Classical Traditions

In ancient times, the underground stem of the plant was used as a detergent. Before commercial soaps were available, it is believed that the ancient Romans grew the plant in order to use its frothy liquid for cleaning the body and hair. The crushed leaves or roots of Saponaria officinalis have been used for washing people and clothes for centuries.

2.2 Medieval and Early Modern European Use

In the Middle Ages, Franciscan and Dominican monks were said to have viewed it as a "divine gift that was meant to keep them clean." Soapwort wash also has a long history of use in Siberia and Romania. The name "fuller's herb" refers to its industrial use by cloth fullers — textile workers who used the plant's lathering properties to cleanse and soften newly woven woollen fabrics, a practice that persisted in European textile towns for centuries. Uses for soapwort's sap included washing delicate fabrics that could not withstand commercial soaps or cleaners and creating a mild skin cleanser that was usually suitable for sensitive and/or irritated skin.

2.3 Medicinal Traditional Use

In traditional herbal medicine, the roots of the species have been used as a diuretic. It was also used for coughs, bronchitis, stomach disorders, bone deformations, rheumatism, pimples, skin diseases, bile disorders, liver problems, and respiratory system diseases.

The saponins in the rootstocks have a slight irritating effect on the respiratory and digestive system, and the herb is regarded to have expectorant, diuretic, diaphoretic, and laxative properties. In herbal medicine, soapwort is mainly used as a remedy for cough, bronchitis, and inflammation of the upper respiratory tract, usually in the form of a decoction.

Throughout history, traditional uses of soapwort included using the plant's roots and leaves to make detergent, to soften skin, and to fight ailments such as poison ivy, other rashes, and respiratory ailments.

One traditional treatment was to make a decoction (boiling dried roots/twigs in water for 15–20 minutes) and applying the liquid to skin to relieve itching. Soapwort has been used throughout history for treatment of skin conditions such as eczema, psoriasis, acne, and boils.

Soapwort also enhances the production and excretion of bile from the liver and gallbladder, and it has been used as a natural treatment for constipation and bile duct diseases. Once, the herb was used internally to reduce rheumatic pain.

2.4 Food and Industrial Use

In the past, soapwort extracts were used as household detergents and cosmetics, mainly due to the emulsifying, cleansing, and foaming properties of its saponin components. Today, one of the major applications of the common species Saponaria officinalis L. is its use as a natural emulsifier in the production of halva, a popular confectionery.

3. Key Constituents and Active Compounds

3.1 Triterpenoid Saponins (Primary Active Class)

Soapwort (Saponaria officinalis) is a flowering plant from the Caryophyllaceae family with a long history of human use as a traditional source of soap. Its detergent properties are due to the production of polar compounds (saponins), of which the oleanane-based triterpenoid saponins, saponariosides A and B, are the major components.

Over 40 different saponins have been isolated from soapwort so far, some with important pharmaceutical properties including potent anticancer activity. The major saponins found in soapwort are saponariosides A and B (SpA and SpB). SpA differs from SpB in having an additional sugar (d-xylose) attached to the d-quinovose group.

A total of six major saponins, including gypsogenin and gypsogenic acid derivatives, as well as saponariosides C, D, and E, were identified using UHPLC/Q-TOF-MS analysis, with gypsogenin derivatives being the most common saponins detected through quantitative analysis.

The saponariosides A–G are a series of glycosides derived from triterpenoid aglycones; gypsogenin-based and quillaic acid-based saponins are saponins with gypsogenin and quillaic acid as the aglycone part, respectively.

The saponins from soapwort have a five-ringed C30 backbone (aglycone) with two hydrophilic sugar units, attached at the 3 and 28 carbons of the hydrophobic aglycone.

Soapwort (Saponaria officinalis) is a rich reservoir of triterpenoid glycosides that often have important pharmaceutical, nutraceutical, and agronomical potential. Research on the S. officinalis genome has identified 14 enzymes that complete the biosynthetic pathway to saponarioside B. These enzymes include a noncanonical cytosolic GH1 (glycoside hydrolase family 1) transglycosidase required for the addition of d-quinovose.

3.2 Saporin (Type I Ribosome-Inactivating Protein)

Saporins are ribosome-inactivating proteins (RIPs) extracted from different tissues of the soapwort plant (Saponaria officinalis L.). While the biosynthesis of these proteins and their roles in planta have received little attention, saporins have been extensively used for the production of targeted toxins for therapeutical and research applications.

Saporin, a type I ribosome-inactivating protein (RIP), removes adenine residues from the 28S ribosomal RNA as part of a process that leads to inhibition of protein synthesis. Saporin by itself has low cytotoxicity because, like other type I RIPs, it lacks the natural cell-binding B domain required for entry into the cell.

Type I RIPs have also been found in Saponaria ocymoides L. (red soapwort specifically), though they are not yet named. There are further variants for each of the named type I RIPs slightly differing in the amino acid sequences.

3.3 Phenolic Compounds and Flavonoids

A total of six phenolic compounds have been identified in S. officinalis root extracts, including rutin, quercetin galactoside, syringic acid, apigenin, protocatechuic acid, and vanillic acid.

In addition to saponins, soapworts contain flavonoids, phenolic compounds, and fatty acids. Caryophyllaceae are known to be a rich source of pharmacologically active secondary metabolites. The major chemical constituents of this family are saponins, flavonoids, ecdysteroids, sterols, lignans, polyphenols, essential oils, and N-containing compounds such as vitamins, alkaloids, and cyclic peptides.

Apigenin, a naturally occurring flavone identified in soapwort root extracts, has been reported to demonstrate antimicrobial activity against S. aureus-resistant bacteria, as well as other health-related effects such as the prevention of oxidative damage caused by reactive oxygen molecules. Quercetin O-glycoside derivatives are well known for their antioxidant properties. The 3-O-rutinoside derivative of quercetin, named rutin, is found in several species of the Caryophyllaceae and has been reported to have a wide range of biological properties.

3.4 Essential Oil Constituents

Phytochemical analysis by GC and GC/MS of the essential oil samples obtained from fresh shoots and flowers of Saponaria officinalis L. allowed the identification of 96 components in total. Regarding the shoots essential oil, the major of 87 identified volatile compounds were phytol (14.1%), tricosane-6,8-dione (13.4%), patchouli alcohol (7.9%), and tricosane (7.2%), whereas patchouli alcohol (20.0%), heneicosane (11.5%), and tricosane (8.4%) were dominant among the 66 volatiles in the flower oil. Non-terpenoid compounds had the highest contribution in S. officinalis shoots essential oil (53.7%), while in the flower oil, constituents were almost evenly distributed between the oxygenated sesquiterpenoid (41.2%) and non-terpenoid compounds (39.5%).

3.5 Additional Minor Constituents

HPLC analysis of S. officinalis callus extract has confirmed the presence of saponarin — a bioactive compound with known anti-inflammatory properties. Tannins found in the plant may contribute to its astringent properties, making it useful in traditional medicine for treating minor wounds and skin irritations. Alkaloids have also been detected in Saponaria officinalis, although present in lower quantities; these compounds can have diverse effects on the body and are an area of ongoing research.

4. Established Mechanisms of Action

4.1 Surfactant and Membrane-Disrupting Action of Saponins

Saponins in general are surface-active compounds that give stable foams in water and have been shown to affect the plasma membrane of living cells and model membranes by interacting with cholesterol. They are mainly produced by plants and are of lower molecular weight (<2 kDa).

According to their aglycone structure, saponins are classified into steroidal and triterpenoid types. Saponins have a high ability to bind to cell membrane sterols, which is responsible at least in part for their biological activities. They also reveal strong hemolytic properties, which differ depending on the saponin type and its aglycone structure.

4.2 Expectorant Mechanism

Soapwort's main medicinal use as an expectorant operates through its strongly irritant action within the gut, which is thought to stimulate the cough reflex and increase the production of a more fluid mucus within the respiratory passages. The saponins in soapwort help to loosen mucus, thus facilitating its expulsion from the respiratory tract.

4.3 Saporin's Ribosome-Inactivating Mechanism

RIP activity is traditionally attributed to rRNA N-glycosylase; this specific depurination leads to a permanent inactivation of the ribosome, irreversibly blocking protein synthesis and inducing DNA damage. Consequently, all RIPs cause cell death by apoptosis at very low dosages.

The ability of saporin-S6 to act on different substrates makes it able to kill cells by triggering several mechanisms of death such as apoptosis and necroptosis, as well as autophagy and oxidative stress.

4.4 Saponin Enhancement of Saporin Cellular Entry

A critical mechanistic finding involves the synergy between the plant's two major toxic constituents: Saporin and his-tagged saporin became highly cytotoxic when used in combined treatment with soapwort saponins (SA). When combined with SA (2–4 μg/ml), saporin became as cytotoxic as the highly toxic type II RIP rViscumin, reflected by an IC50 of 42.5 × 10⁻¹² M for saporin. It was demonstrated that saporin was internalized via clathrin-mediated endocytosis, followed by the release into the endosomal transport system. The results indicate that soapwort saponins trigger this endocytic event, rendering the otherwise cell membrane-impermeable type I RIP saporin a potent cytotoxin.

Soapwort saponins markedly enhance the cytotoxicity of saporin by initiating endosomal escape of internalized saporins into the cytosol where they exert their toxicity, leading to interest in these compounds as endosomal escape enhancers for targeted tumor therapies.

4.5 Anti-Inflammatory Mechanism

In vitro assays on S. officinalis callus extract demonstrated that the extract significantly suppressed nitric oxide production and reduced the expression of pro-inflammatory mediators, including iNOS, COX-2, TNF-α, IL-1β, and IL-6, in LPS-stimulated RAW264.7 macrophages. Saponins from S. officinalis have shown significant anti-inflammatory effects that are mediated through the inhibition of cytokines.

5. Scientific Evidence by Area of Use

5.1 Respiratory Health (Expectorant / Anti-cough)

Traditional basis: Soapwort has traditionally been used to treat cough and bronchitis.

Scientific evidence: Clinical evidence is lacking to support specific dosing recommendations. Doses of 1 to 2 g daily of soapwort extract or 1.5 g daily of the root have been traditionally used for bronchitis and cough. Evidence is lacking to corroborate its expectorant effects in humans. The proposed mechanism — irritation of gastrointestinal mucosa reflexively increasing bronchial secretions — is pharmacologically plausible given saponin chemistry, but has not been validated in controlled human clinical trials. Evidence in this area remains at the level of traditional use and mechanistic theory.

Evidence strength: Weak — no published randomised controlled trials (RCTs) in humans identified in the peer-reviewed literature as of the available evidence.

5.2 Skin Conditions and Topical Applications

Traditional basis: Soapwort has been used topically to treat various skin conditions, including eczema, psoriasis, and acne, due to its cleansing and anti-inflammatory properties.

In vitro and skin-model evidence: A 2021 study published in Molecules compared soapwort extract with four synthetic surfactants (SLS, SLES, ALS, CAPB) on human skin cell models. The soapwort extract (SAP) did not show a cytotoxic effect on normal human keratinocytes (HaCaT) in the dry mass range up to 0.039%, in contrast to all four tested synthetic surfactants which were toxic already above 0.02%. At dry mass contents below 0.6%, the soapwort extract is less harmful than SLS, SLES, CAPB, or even the gentlest from this group — ALS. The soapwort extract affects the skin models to a clearly different extent than any of the tested synthetic surfactants, and its protein and lipid solubilising potential are much smaller than for the three anionic surfactants (SLS, ALS, SLES).

A 2025 study published in Plants (PMC) investigated S. officinalis callus as a novel exfoliating cosmetic ingredient. The callus extract (SCE) was analyzed via HPLC, confirming the presence of saponarin — a bioactive compound with known anti-inflammatory properties. In vitro assays demonstrated that SCE significantly suppressed nitric oxide production and reduced the expression of pro-inflammatory mediators, including iNOS, COX-2, TNF-α, IL-1β, and IL-6, in LPS-stimulated RAW264.7 macrophages. The foaming ability and stability of the callus and SCE were also comparable to commercial surfactants.

Evidence strength: Preliminary — in vitro and skin-mimetic model data only. No RCTs in human subjects have been identified in the peer-reviewed literature. Cosmetic applications as a gentle surfactant are supported by laboratory data.

5.3 Antimicrobial Activity

Extracts from Saponaria officinalis have antioxidant properties and methanol extracts have antimicrobial actions against a wide range of bacteria, including many human pathogens.

A 2024 study in Plants (PMC, MDPI) on root extracts of Saponaria officinalis from Cyprus found: All samples demonstrated antioxidant capacity, as well as antibacterial activity, against four bacterial strains (Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, and Salmonella enteritidis), with the acetone extract presenting higher susceptibility.

A 2022 PMC-published study on Saponaria cypria (a related Cypriot species) found: Root extracts demonstrated antibacterial potential against Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, and Salmonella enteritidis. S. aureus presented the highest susceptibility among all bacteria tested. The saponins also exhibit antimicrobial properties against a variety of pathogens, including bacteria and fungi.

A 2024 study noted it was the first to identify the type of flavonoids in S. officinalis root extracts and quantify their concentration, and that the fact that these extracts are a good source of phenolic compounds may contribute to their important antioxidant and antimicrobial role.

Evidence strength: Preliminary — limited to in vitro assays. No human clinical trials on antimicrobial use have been identified.

5.4 Antioxidant Activity

Members of the Saponaria genus have been shown to possess antioxidant, antimicrobial, antiscrophulatic, and antiproliferative activities. Laboratory analysis of S. officinalis ethanol and acetone root extracts demonstrated measurable antioxidant capacity using DPPH and TEAC assays; the ethanol and acetone extracts demonstrated similar TEAC values (2.047% and 2.743%, respectively), whereas the methanol extract was significantly lower (0.113%, p < 0.05).

Evidence strength: Preliminary — in vitro antioxidant assay data only. No clinical trials in humans have been identified.

5.5 Oncology / Anticancer Research (Saporin-Based Immunotoxins)

This is the area where the most significant scientific and clinical research on soapwort-derived compounds has been conducted. The research focuses not on whole plant extracts or dietary supplementation, but on purified saporin as a toxic "warhead" in immunotoxin constructs.

Saponins and saporin have been conjugated with monoclonal antibodies (i.e., rituximab) and growth factors to be used as targeted antitumor toxin and antiviral therapy; however, clinical trials are lacking to support these uses as dietary or supplement applications.

Plant ribosome-inactivating proteins (RIPs) including the type I RIP saporin have been used for the construction of immunotoxins (ITxs) obtained via chemical conjugation of the toxic domain to whole antibodies or by generating genetic fusions to antibody fragments/targeting domains able to direct the chimeric toxin against a desired sub-population of cancer cells. The high enzymatic activity, stability and resistance to conjugation procedures and especially the possibility to express recombinant fusions in yeast make saporin a well-suited tool for anti-cancer therapy approaches.

Early phase clinical trial data: In early phase 1/2 clinical trials (1992 to 1996) using saporin-S6 immunotoxin conjugates, saporin-S6 was administered at a dose of 0.2 mg/kg in 1 or 2 weekly doses intravenously in patients with advanced Hodgkin disease, or in weekly infusions of 1 to 4 mg/dose (for a total of 5 to 20 mg) in patients with B-cell lymphoma.

Small pilot studies across multiple hematological malignancies were conducted. Published data from Toxins (MDPI, 2018) summarize: Clinical studies included BER-H2/SO6 targeting CD30 in Hodgkin's lymphoma (4 patients, pilot, 3 partial responses); BsAb1 + BsAb2 targeting CD22 in B-cell lymphoma (5 patients, pilot, 4 partial responses); BU12-Saporin targeting CD19 in B-cell lymphoma (8 patients, Phase I, maximum tolerated dose not reached); OKT10-Saporin targeting CD38 in myeloma (10 patients, Phase I, maximum tolerated dose not reached); and BU12-Saporin targeting CD19 in pediatric ALL (5 patients, Phase I, maximum tolerated dose not reached).

High efficacy was reported in clinical trials with saporin-S6-containing immunotoxins, at dosages that induced only mild and transient side effects, which were mainly fever, myalgias, hepatotoxicity, thrombocytopenia, and vascular leak syndrome.

Previous clinical work on RIPs-based immunotoxins (including saporin) has shown that several critical issues must be taken into deeper consideration to fully exploit their therapeutic potential. Saporin has been largely investigated as an antitumor agent in several clinical trials but with mixed success, due to toxicity problems also common to other ribosome-inactivating proteins (RIPs) that have substantially hampered their employment in a clinical setting.

Soapwort saponins have anticancer properties and are also of interest as endosomal escape enhancers for targeted tumor therapies. Intriguingly, these saponins share common structural features with the vaccine adjuvant QS-21 and thus represent a potential alternative supply of saponin adjuvant precursors.

Some studies have reported the cytotoxic effects of saponins from S. officinalis on cancer cell lines, indicating their potential as antitumor agents. However, this observation might be somewhat surprising given the numerous literature reports on the potential anticancer activity of many saponins; the literature reports comparing the effect of the same saponin (or saponin mixture) on normal and cancerous cells are still rather scarce. There is not much scientifically-sound proof confirming that saponins show general selectivity towards cancerous cells.

Evidence strength: Small, early-phase clinical trials with saporin-based immunotoxins in hematological cancers showed partial responses and manageable toxicity in limited patient numbers. These constructs are not dietary supplements. As a supplement or plant extract, there is no human clinical evidence for anticancer use. Preclinical and in vitro data for saponins are preliminary.

5.6 Gastric Acid Inhibition

Ethanol extract of soapwort inhibits the gastric enzyme hydrogen potassium ATPase that produces stomach acid. This in vitro finding is mechanistically relevant given the plant's historical use in stomach and digestive complaints, but no human clinical trial data have been identified in this area.

Evidence strength: In vitro only. No human data.

6. Body Systems and Health Areas Associated With Red Soapwort

• Respiratory system: Traditionally used as an expectorant and mucolytic for cough and bronchitis; saponin-mediated irritation of digestive mucosa is proposed to reflexively increase bronchial secretions.
• Integumentary system (skin): Traditional and contemporary cosmetic use for cleansing, exfoliation, and managing eczema, psoriasis, and acne; in vitro anti-inflammatory activity demonstrated in cell models.
• Hepatobiliary system: Traditional use as a cholagogue to stimulate bile production and excretion; used historically for bile duct and liver complaints.
• Digestive / gastrointestinal system: Used traditionally as a laxative and for constipation; saponins irritate GI mucosa, which is both a mechanism of expectorant action and a source of adverse effects at higher doses.
• Urinary system: Traditional diuretic use.
• Musculoskeletal system: Historical internal use for rheumatic pain (now largely discontinued given toxicity concerns).
• Oncology (research context): Saporin extracted from the plant has been investigated in targeted immunotoxin therapies for hematological malignancies.

7. Dosage Forms and Reported Dosages

Clinical evidence is lacking to support specific dosing recommendations. The following dosages appear in the reviewed literature strictly as reported historically or in early research contexts:

• Bronchitis and cough (traditional): Doses of 1 to 2 g daily of soapwort extract or 1.5 g daily of the root have been traditionally used.
• Saporin-S6 immunotoxin (oncology clinical trials, intravenous, not dietary supplement): In early phase 1/2 clinical trials (1992 to 1996), saporin-S6 was administered at a dose of 0.2 mg/kg in 1 or 2 weekly intravenous doses in patients with advanced Hodgkin disease, or in weekly infusions of 1 to 4 mg/dose (for a total of 5 to 20 mg) in patients with B-cell lymphoma.
• Saponin content of root dry mass: Soapwort amphiphilic saponins applicable in cosmetic products have a measured saponin content of 50.92 ± 2.40 mg/g dry mass.

No dosage from a registered pharmacopeia monograph specific to S. ocymoides was identified in the sources reviewed. Dosage information available pertains primarily to S. officinalis.

8. Safety Considerations and Toxicology

8.1 Saponin Toxicity

Soapwort should never be consumed in a large dosage or over a long period of time because the saponin content of the herb can cause hemolysis, and severe irritation of the digestive tract resulting in cramps, nausea, vomiting, and diarrhea.

When taken in excess, saponins destroy red blood cells and cause paralysis of the vasomotor centre. If saponins enter the bloodstream directly (via injection), they can destroy red blood cells, causing hemolysis. This uncommon occurrence highlights the need to handle saponins with care in medical settings.

Although poisonous, saponins also have a range of medicinal applications and many saponin-rich plants are used in herbalism (particularly as emetics, expectorants, and febrifuges) or as sources of raw materials for the pharmaceutical industry. Saponins have a quite bitter flavour and are in general poorly absorbed by the human body, so most pass through without harm.

8.2 Adverse Events Observed in Immunotoxin Trials

While not relevant to dietary supplement use, the clinical trial record provides the only human safety data associated with soapwort constituents administered systemically. In early clinical trials of saporin-S6–containing immunotoxins for antitumor targeted toxin therapy, mild transient adverse reactions occurred, including fever, myalgia, transient increases in transaminases, weakness, thrombocytopenia, and vascular leak syndrome.

8.3 Gastrointestinal Adverse Effects

Severe vomiting and diarrhea may occur if soapwort is ingested. External use should be done with caution, as soapwort can cause irritation to sensitive skin or when it comes into contact with the eyes.

8.4 Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking.

8.5 Special Populations and Contraindications

Women with vaginal infections should not use soaps or cleansing products made with soapwort. Based on the known pharmacology of saponins, internal use in individuals with peptic ulcer disease, pre-existing gastrointestinal inflammation, or hemolytic disorders carries theoretical risk; however, formal interaction studies have not been identified in the peer-reviewed literature reviewed for this article.

8.6 Drug Interactions

No drug interactions are well documented in the reviewed clinical literature. The saponin-mediated alteration of membrane permeability and endocytic pathways is known to affect the cellular uptake of other molecules in vitro (as demonstrated in the saporin co-administration studies), but this has not been characterised as a clinically relevant drug interaction in humans in any identified source.

8.7 General Safety Status

To date, there is not enough data to prove the safety and efficacy of soapwort. The saponin-rich extracts demonstrate strong biological activity and may potentially be used as alternative medications for disorders such as heart disease, chronic inflammatory disease, and cancer, but robust clinical trial validation is lacking.

References

• Charalambous D. et al. "Saponin and Phenolic Composition and Assessment of Biological Activities of Saponaria officinalis L. Root Extracts." Plants 2024;13:1982. PMC/MDPI (Open Access).
• Charalambous D. et al. "Antimicrobial Activities of Saponaria cypria Boiss. Root Extracts, and the Identification of Nine Saponins and Six Phenolic Compounds." PMC/NIH, 2022.
• Lu Y. et al. "Unlocking saponin biosynthesis in soapwort." Nature Chemical Biology, 2024. PMC/NIH.
• Weng A., Bachran C., Fuchs H., Melzig M. "Soapwort saponins trigger clathrin-mediated endocytosis of saporin, a type I ribosome-inactivating protein." Chemico-Biological Interactions 2008;176:204–211. PubMed.
• Jurek I. et al. "Soapwort (Saponaria officinalis L.) Extract vs. Synthetic Surfactants — Effect on Skin-Mimetic Models." Molecules 2021;26:5628. PMC/NIH.
• Evaluation of Saponin-Rich Callus from Saponaria officinalis L. as a Novel Scrub Material with Significant Exfoliating and Anti-Inflammatory Effects. Plants 2025. PMC/NIH.
• Fabbrini M.S. et al. "Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins." Toxins 2018;10:82. PMC/NIH.
• Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells. PMC/NIH, 2022.
• Phytochemical analysis of Saponaria officinalis L. shoots and flowers essential oils. PubMed, 2017.
• Drugs.com Natural Products Database: Soapwort Uses, Benefits & Dosage (Medically reviewed, last updated March 23, 2026).
• Wikipedia: Saponaria ocymoides.
• Missouri Botanical Garden Plant Finder: Saponaria ocymoides.
• NC State Extension Gardener Plant Toolbox: Saponaria ocymoides (Rock Soapwort).
• Wikipedia: Saponaria officinalis.
• University of Iowa Libraries, Roots of Medicine: Soapwort.
• The Genus Allochrusa: A Comprehensive Review including Caryophyllaceae phytochemistry context. Diversity 2023;15:574. MDPI.
• Bortolotti M. et al. "The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells." Leukemia 2004. Nature Publishing Group.
• High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin. PMC/NIH.
• Polito L. et al. "Saporin-S6: A Useful Tool in Cancer Therapy." Toxins 2013;5:1698–1722. MDPI.
• Temperate Plants Database (Ken Fern): Saponaria ocymoides.
• Plant-derived saponins and their prospective for cosmetic and personal care products. PMC/NIH, 2024.